Global medical device manufacturer and distributor Devon Medical has obtained CE mark approval for its portable would healing system, extriCARE.
With the approval in place, the company will soon launch the extriCARE negative pressure wound therapy (NPWT) system in Europe, and start selling it across the EU and CE mark territories.
The system integrates the company’s anatomically fitted NPWT dressings, which will be applied to wounds to create a tight seal, and comprises the extriCARE 2400 pump, which creates a negative pressure or vacuum environment to draw blood to the wound bed.
The NPWT process, which is more commly used in facility settings, including hospitals, nursing homes and long-term care facilities, filters out exudates into a disposable canister affixed to the back of the pump.
Devon Medical founder and CEO Dr John Bennett said that the device is already used in the US to manage non-healing wounds, including diabetic ulcers and chronic, acute, traumatic, subacute and dehisced wounds.
"The device’s portability allows patients to receive wound healing treatment inside of their own home while participating in normal daily activities," Bennett said.
"We are excited to receive the CE mark as it will allow us to work with healthcare professionals to achieve similar patient compliance and positive outcomes across Europe and other parts of the world."
The company plans to launch extriCARE at the European Wound Management Association (EWMA) Conference in Copenhagen, Denmark, on 15-17 May.